Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Mirum to acquire Bluejay Therapeutics

Lucid Diligence Brief: Mirum to acquire Bluejay Therapeutics Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Regeneron and Tessera team on TSRA-196 for AATD

Lucid Diligence Brief: Regeneron and Tessera team on TSRA-196 for AATD…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Protego Biopharma $130M Series B

Lucid Diligence Brief: Protego Biopharma $130M Series B Professional audiences…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Chiesi partners with Aliada (AbbVie) on BBB platform for LSDs

Lucid Diligence Brief: Chiesi partners with Aliada on BBB platform for LSDs…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Electra Therapeutics $183M Series C

Lucid Diligence Brief: Electra Therapeutics $183M Series C Professional…


Artificial_Intelligence

Artificial Intelligence and Digital Health Weekly News - July 17th 2025

AI and Digital Health Update: Xealth Joins Samsung, ECG‑AI Stroke Alerts &…


Endocrinology

Endocrinology Weekly Update - July 8th 2025

🧬 Endocrinology Update: Acromegaly Heart Breakthrough, AI in Diabetes, New…


Artificial_Intelligence

Artificial Intelligence and Digital Health Weekly News - July 7th 2025

AI and Digital Health Update: MSK’s Woollie Beats ChatGPT, Centaur Maps…


ASCGT 2025 PREVIEW

ASGCT 2025 Preview

🔬 ASGCT 2025: Transforming Medicine with Gene Editing, Cell Therapies &……


Privacy Preference Center